During the past decade, Southern California Research Center conducted 47 clinical trials. In the 10-year time frame, 47 clinical trials started and 22 clinical trials were completed, i.e. on average, 46.8% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 21 clinical trials were completed. i.e. 123.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Southern California Research Center" #1 sponsor was "Gilead Sciences" with 5 trials, followed by "Assembly Biosciences" with 4 trials sponsored, "Bristol-Myers Squibb" with 3 trials sponsored, "Enanta Pharmaceuticals, Inc" with 3 trials sponsored and "Grifols Therapeutics LLC" with 3 trials sponsored. Other sponsors include 27 different institutions and companies that sponsored additional 30 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Southern California Research Center" #1 collaborator was "Gilead Sciences" with 2 trials as a collaborator, "Instituto Grifols, S.A." with 2 trials as a collaborator, "Novo Nordisk A/S" with 2 trials as a collaborator, "Triangle Biostatistics" with 2 trials as a collaborator and "CTI Clinical Trial and Consulting Services" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Southern California Research Center" are "Chronic Hepatitis B" (4 trials), "Nonalcoholic Steatohepatitis" (4 trials), "Chronic Hepatitis C" (3 trials), "Cirrhosis" (3 trials) and "Crohn's Disease" (3 trials). Many other conditions were trialed in "Southern California Research Center" in a lesser frequency.

Most popular intervention types in "Southern California Research Center" are "Drug" (47 trials), "Other" (5 trials), "Biological" (4 trials), "Device" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (24 trials), "Ribavirin" (4 trials), "ABI-H0731" (2 trials), "Cilofexor" (2 trials) and "Faldaprevir" (2 trials). Other intervention names were less common.

The vast majority of trials in "Southern California Research Center" are 50 trials for "All" genders.

Currently, there are NaN active trials in "Southern California Research Center". undefined are not yet recruiting, 10 are recruiting, 5 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 25 completed trials in Southern California Research Center, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Southern California Research Center, 6 "Phase 1" clinical trials were conducted, 30 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".